Involvement of Ca2+-independent phospholipase A2 in the translocation of hypoxia-inducible factor-1α to the nucleus under hypoxic conditions

European Journal of Pharmacology

Volumn 549, Issue 1-3, 2006, Pages 58-62

  Osada Oka, Mayuko ^a   Takahashi, Minoru ^a   Akiba, Satoshi ^a   Sato, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bromoenol lactone; Ca2+ independent phospholipase A2; Hypoxia; Hypoxia inducible factor 1

Indexed keywords

BROMOENOL LACTONE; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; MESSENGER RNA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHONIC ACID DERIVATIVE; ARACHIDONIC ACID DERIVATIVE; CALCIUM; HYBRID PROTEIN; METHYL ARACHIDONYLFLUOROPHOSPHONATE; PHOSPHOLIPASE A; VASCULOTROPIN A;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; DNA BINDING; DNA RESPONSIVE ELEMENT; EXPOSURE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSPORT KINETICS; ACTIVE TRANSPORT; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOBLOTTING; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ARACHIDONIC ACIDS; CALCIUM; CELL HYPOXIA; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; LUCIFERASES; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPASES A; PHOSPHONIC ACIDS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33748964448     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.026     Document Type: Article

References (26)

1. 2. Biol. Pharm. Bull. 27 (2004) 1174-1178
2. 1 cells. J. Biol. Chem. 274 (1999) 19906-19912
3. 1 cells. Biochem. Pharmacol. 63 (2002) 1969-1977
4. 1 macrophages. J. Biol. Chem. 271 (1996) 6758-6765
5. 2. Biochim. Biophys. Acta 1488 (2000) 40-47
6. Goldberg M., Zhang H.L., and Steinberg S.F. Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J. Clin. Invest. 99 (1997) 55-61
7. 2 and PDGF in mesangial cells. Am. J. Physiol., Renal Physiol. 282 (2002) F485-F491
8. 2. Biol. Pharm. Bull. 27 (2004) 1168-1173
9. Kallio P.J., Okamoto K., O'Brien S., Carrero P., Makino Y., Tanaka H., and Poellinger L. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J. 17 (1998) 6573-6586
10. Kamura T., Sato S., Iwai K., Czyzyk-Krzeska M., Conaway R.C., and Conaway J.W. Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10430-10435
11. 2 by methyl arachidonyl fluorophosphonate. Biochim. Biophys. Acta 1302 (1996) 55-60
12. Liu Q., Moller U., Flugel D., and Kietzmann T. Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1. Blood 104 (2004) 3993-4001
13. 2β in INS-1 insulinoma cells. Am. J. Physiol., Endocrinol Metabol. 282 (2002) E820-E833
14. 2β, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition. J. Biol. Chem. 278 (2003) 22231-22236
15. 2 in hypoxic ventricular myocytes. Am. J. Physiol. 274 (1998) C1727-C1737
16. Minet E., Michel G., Mottet D., Raes M., and Michiels C. Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic. Biol. Med. 31 (2001) 847-855
17. 2. J. Biochem. 131 (2002) 285-292 (Tokyo)
18. Ohigashi T., Mallia C.S., McGary E., Scandurro A.B., Rondon I., Fisher J.W., and Beckman B.S. Protein kinase C α protein expression is necessary for sustained erythropoietin production in human hepatocellular carcinoma (Hep3B) cells exposed to hypoxia. Biochim. Biophys. Acta 1450 (1999) 109-118
19. Osada M., Imaoka S., Sugimoto T., Hiroi T., and Funae Y. NADPH-cytochrome P-450 reductase in the plasma membrane modulates the activation of hypoxia-inducible factor 1. J. Biol. Chem. 277 (2002) 23367-23373
20. Osada M., Imaoka S., and Funae Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1α protein. FEBS Lett. 575 (2004) 59-63
21. Pemberton L.F., and Paschal B.M. Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 6 (2005) 187-198
22. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64 (2002) 993-998
23. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12 (1992) 5447-5454
24. 2 activity is required for nuclear shrinkage in caspase-independent cell death. J. Cell Biol. 163 (2003) 1219-1230
25. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488 (2000) 1-19
26. 2 tension. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5510-5514